3 UK Stocks Estimated Up To 47.6% Undervalued Offering A 22.9% Discount Opportunity
The United Kingdom's FTSE 100 index has recently faced challenges, closing lower due to weak trade data from China and concerns about the global economic recovery. In this environment of uncertainty, identifying undervalued stocks can present opportunities for investors seeking potential value in the market.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Yü Group (AIM:YU.) | £17.60 | £33.58 | 47.6% |
| Living REIT (LSE:LIVE) | £0.796 | £1.57 | 49.2% |
| Kistos Holdings (AIM:KIST) | £2.70 | £5.35 | 49.5% |
| Fevara (LSE:FVA) | £1.48 | £2.86 | 48.3% |
| FDM Group (Holdings) (LSE:FDM) | £1.20 | £2.34 | 48.7% |
| Eurocell (LSE:ECEL) | £1.175 | £2.22 | 47% |
| Entain (LSE:ENT) | £5.54 | £10.86 | 49% |
| CVS Group (LSE:CVSG) | £13.01 | £23.89 | 45.5% |
| Bridgepoint Group (LSE:BPT) | £3.086 | £6.01 | 48.7% |
| Accsys Technologies (AIM:AXS) | £0.76 | £1.46 | 47.8% |
Below we spotlight a couple of our favorites from our exclusive screener.
Yü Group (AIM:YU.)
Overview: Yü Group PLC, with a market cap of £305.06 million, operates through its subsidiaries to supply energy and utility solutions primarily in the United Kingdom.
Operations: The company generates revenue from several segments, including £10.90 million from Smart, £700 million from Retail, and £1.80 million from Metering Assets.
Estimated Discount To Fair Value: 47.6%
Yü Group is trading at 47.6% below its estimated fair value, indicating strong undervaluation based on discounted cash flow analysis. Its revenue is expected to grow at 25% annually, outpacing the UK market's growth rate. While earnings are forecasted to increase by 13.67% per year, the company has an unstable dividend track record despite recent increases. A strategic extension of a hedging facility with Shell Energy supports ambitious growth plans and enhances financial flexibility without tying up capital in volatile markets.
- The growth report we've compiled suggests that Yü Group's future prospects could be on the up.
- Click to explore a detailed breakdown of our findings in Yü Group's balance sheet health report.
Burberry Group (LSE:BRBY)
Overview: Burberry Group plc, along with its subsidiaries, operates in the manufacturing, retail, and wholesale of luxury goods under the Burberry brand across regions including the Asia Pacific, China, Europe, the Middle East, India, Africa, and the Americas; it has a market cap of approximately £3.89 billion.
Operations: The company's revenue segments consist of £2.36 billion from Retail/Wholesale and £62 million from Licensing.
Estimated Discount To Fair Value: 40.8%
Burberry Group is trading at £10.87, significantly below its estimated future cash flow value of £18.36, highlighting its undervaluation potential. Earnings are forecast to grow substantially at 34.5% annually, surpassing the UK market's growth rate of 11.4%. However, revenue growth is projected at a modest 5.2% per year. Recent leadership changes with William Jackson's appointment as Chair may influence strategic direction and financial performance positively in the long term.
- Upon reviewing our latest growth report, Burberry Group's projected financial performance appears quite optimistic.
- Dive into the specifics of Burberry Group here with our thorough financial health report.
Rentokil Initial (LSE:RTO)
Overview: Rentokil Initial plc, along with its subsidiaries, offers route-based services across North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey and the Pacific with a market cap of £11.23 billion.
Operations: The company's revenue is primarily derived from its North America Pest Control segment at $4.15 billion, followed by International Pest Control at $1.56 billion, International Hygiene & Wellbeing at $1.06 billion, and North America Hygiene & Wellbeing at $146 million.
Estimated Discount To Fair Value: 22.9%
Rentokil Initial is trading at £4.46, below its estimated future cash flow value of £5.79, suggesting undervaluation. Despite a forecasted low return on equity of 14.1%, earnings are expected to grow significantly at 20.1% annually, outpacing the UK market's growth rate of 11.4%. However, operating cash flow does not adequately cover debt obligations. Recent executive appointments may enhance strategic execution and operational efficiency, particularly in North America under new leadership by Rafael Rafa Carrasco.
- Our growth report here indicates Rentokil Initial may be poised for an improving outlook.
- Unlock comprehensive insights into our analysis of Rentokil Initial stock in this financial health report.
Turning Ideas Into Actions
- Discover the full array of 44 Undervalued UK Stocks Based On Cash Flows right here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com